Neo-Predef with Tetracaine Powder for Dogs, Cats and Horses - 15 grams

Neo-Predef with Tetracaine Powder is indicated in the treatment or adjunctive therapy of certain ear and skin conditions in dogs, cats, and horses caused by or associated with neomycin-susceptible organisms and/or allergy. In addition, Neo-Predef with Tetracaine Powder is indicated as superficial dressing applied to minor cuts, wounds, lacerations, abrasions, and for post-surgical application where reduction of pain and inflammatory response is deemed desirable. It may also used as a dusting powder following amputation of tails, claws, and dew-claws; following ear trimming and castrating; and following such surgical procedure as ovariohysterectomies. Highly potent anti-inflammatory effect of isoflupredone acetate. Wide-spectrum bactericidal effect of neomycin. Rapid anesthetic effect of tetracaine. Reduces further self-inflicted trauma. Ease of application. Adherent to moist surfaces. A prescription isrequired for these petmeds. Click here for details Application : After cleansing the affected area, Neo-Predref wth Tetracaine Powder is applied by compressing the sides of the container with short, sharp squeezes. in most instances a single daily application will be sufficient; however, it may be applied one to three times daily, as required. Description: Neo-Predef with Tetracaine Powder contains in each gram neomycin sulfate, 5 mg (equivalent to 3.5mg neomycin); isoflupredone acetate, 1 mg; tetracaine hydrochloride, 5 mg; myristyl-gamma-picolinium chloride, o.2 mg; also lactose hydrous. Because of the prompt, potent, and specific actions of the individual components, this combination is well suited for the treatment of certain ear and skin conditions occuring in dogs, cats, and horses. Storage: Store in dry place at controlled room temperature (68° to 77°F). Warnings: Not for human use. Clinical and experimental data have demonstrated that costicosteroids administered orally or by injection to animals may induce the first stage of parturition if used during the last trimester of pregnancy and may precipitate premature parturition followed by dystorcia, fetal death, retained placenta and metritis.